PRESS RELEASES
The Weber Foundation and the Spanish Association of Orphan and Ultra Orphan Drug Laboratories(AELMHU) have presented the conclusions of the report "Differential aspects of orphan drugs and their value from a social perspective", which highlight the positive impact of these therapeutic innovations on patients and their environment, as well as their ability to significantly reduce costs to the system.
Prepared by the Weber Foundation, with the collaboration of AELMHU, the Report analyzes the differential characteristics of these therapies and the value they generate in different areas of society, in addition to the substantial benefit on the health and quality of life of patients and their environment.
Access the full press release here.